Related Experiment Video

Updated: Jul 6, 2026

Models of Bone Metastasis
08:49

Models of Bone Metastasis

Published on: September 4, 2012

[Role of PGE2 in bone metastatic cancer]

Masaki Inada1, Chisato Miyaura

  • 1Tokyo University of Agriculture and Technology, Department of Biotechnology and Life Science.

Clinical Calcium
|April 2, 2008
PubMed

Insights

Prostaglandin E(2) (PGE(2)) plays a key role in bone resorption during cancer metastasis. Blocking the EP4 receptor reduces osteoclast formation, indicating PGE(2) is crucial for bone metastasis.

Area of Science:

  • Biochemistry
  • Oncology
  • Bone Biology

Context:

  • Prostaglandin E(2) (PGE(2)) is a critical lipid mediator involved in maintaining physiological balance and disease development.
  • Bone metastasis is a significant complication of cancer, leading to severe morbidity.

Purpose:

  • To investigate the role of Prostaglandin E(2) (PGE(2)) in a B16 melanoma bone resorptive metastatic model.
  • To elucidate the mechanism by which cancer promotes bone resorption.

Summary:

  • Prostaglandin E(2) (PGE(2)) mediates bone resorption in a B16 melanoma metastasis model.
  • Administration of an EP4 receptor antagonist inhibited RANKL expression in osteoblasts and subsequent osteoclast formation induced by B16 melanoma cells.
  • These findings suggest that cancer-induced bone resorption involves PGE(2) production by host osteoblasts, a key mechanism in bone metastasis.

Impact:

  • This study highlights Prostaglandin E(2) (PGE(2)) and its EP4 receptor as potential therapeutic targets for managing bone metastasis.
  • Understanding the interplay between cancer cells and bone microenvironment can lead to novel treatment strategies.

Related Concept Videos

Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...